Skip to main content
Equibles
UNH logo

UNH · Unitedhealth Group Inc · Metrics

Track UNH — free

Use UNH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UNH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$418.09 -6.89 (-1.62%) At close · Oct 23
S&P 500 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$375.28B
Shares
897.59M
Volume · Oct 23 3.9M Avg daily vol (3M) 5.06M

UNH metrics

116 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$418.09
Market cap
$375.28B

Price action

20 metrics
Price change (1W)
+4.2%
Price change (30D)
+11.0%
Price change (3M)
-0.6%
Price change (6M)
+17.8%
Price change (YTD)
+26.7%
Price change (1Y)
+16.0%
Trailing year
Price change (5Y)
-6.9%
52-week high
$436.35
52-week low
$259.02
Change from 52-week high
-4.2%
Change from 52-week low
+61.4%
Annualized volatility
34.9%
Annualized volatility (3M)
23.7%
Beta
0.4
RSI (14D)
66.0
Price vs SMA 50
+7.6%
Price vs SMA 200
+15.8%
Avg volume (3M)
5.06M
Relative volume
0.8
Average dollar volume
$1.99B

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
897.59M

Valuation

12 metrics
P / E (TTM)
26.8
Trailing earnings · reciprocal yield 3.7%
PEG ratio
0.4
EV / revenue
0.9×
reciprocal yield 107.9%
EV / EBITDA
16.1×
reciprocal yield 6.2%
EV / EBIT
19.2×
reciprocal yield 5.2%
P / sales
0.8×
reciprocal yield 119.9%
P / book
3.6
reciprocal yield 27.8%
FCF yield
6.3%
TTM · current market cap
Buyback yield
0.4%
P / FCF
15.9
reciprocal yield 6.3%
P / operating cash flow
13.9
reciprocal yield 7.2%
Earnings yield
3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
24.6×
reciprocal yield 4.1%
P / E historical average (5Y)
24.8×
reciprocal yield 4.0%
EV / revenue historical average (3Y)
1.1×
reciprocal yield 91.6%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 77.8%
EV / EBIT historical average (3Y)
15.6×
reciprocal yield 6.4%
EV / EBIT historical average (5Y)
16.9×
reciprocal yield 5.9%
EV / EBITDA historical average (3Y)
13.6×
reciprocal yield 7.4%
EV / EBITDA historical average (5Y)
14.8×
reciprocal yield 6.8%

Dividends & buybacks

7 metrics
Dividend yield
2.2%
Trailing 12 months
Payout ratio
57.3%
Shareholder yield
2.6%
Dividend / share (TTM)
$9.06
Dividend growth YoY
+5.1%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-14

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-13

Profitability

9 metrics
Gross margin
88.6%
Operating margin
4.8%
Trailing 12 months
Net margin
3.1%
Gross profit (TTM)
$398.69B
Operating profit (TTM)
$21.68B
Net income (TTM)
$14.12B
Trailing 12 months
Diluted EPS (TTM)
$15.58
FCF margin
5.2%
Effective tax rate
14.5%

Per share

11 metrics
Revenue per diluted share (TTM)
$495.72
Gross profit per diluted share (TTM)
$439.06
Operating profit per diluted share (TTM)
$23.87
EBITDA per diluted share (TTM)
$28.59
Net income per diluted share (TTM)
$15.55
Operating cash flow per diluted share (TTM)
$29.76
Free cash flow per diluted share (TTM)
$26.02
Capital expenditures per diluted share (TTM)
$3.74
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.13
Book value per share
$110.47

Growth

11 metrics
Revenue growth YoY
+0.4%
Year over year
Net income growth YoY
+61.0%
Revenue (TTM)
$450.13B
Trailing 12 months
EPS growth YoY
+61.5%
Shares change YoY
-0.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.4%
Revenue CAGR (5Y)
+11.7%
EPS CAGR (3Y)
-14.5%
EPS CAGR (5Y)
-3.8%
FCF CAGR (3Y)
-11.8%
FCF CAGR (5Y)
-4.4%

Quality

14 metrics
Return on equity
13.5%
Return on assets
4.6%
Debt / equity
0.7
Current ratio
0.8
EBITDA (TTM)
$25.96B
Free cash flow (TTM)
$23.62B
Quick ratio
—
Interest coverage
5.6
Net debt / EBITDA
1.6
Return on invested capital
12.7%
Trailing 12 months
Net cash
−$41.86B
Latest balance sheet
Cash & equivalents
$28.59B
Total assets
$309.73B
Total debt
$73.33B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$27.02B
Capital expenditures (TTM)
$3.40B
R&D (TTM)
—
SG&A (TTM)
$61.88B
Stock compensation (TTM)
$1.02B
R&D / revenue
—
Stock compensation / revenue
0.2%

Ownership (13F)

9 metrics
13F filers
3,423
13F filer change QoQ
+348
Institutional ownership
95.4%
Conviction holders (share of 13F filers)
3.2%
Crowding (high-turnover and private-fund holders)
13.2%
Private-fund adviser ownership
12.5%
Active holders' share change QoQ
+6.0%
Holder tenure
19.6
Price vs estimated holder cost
+11.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
19.3%

Short interest

3 metrics
Short interest
1.8%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$660,910
Insider-sentiment score
49 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 731766 CUSIP 91324P102 13F (30d) 1030 filings 1002 filers Visit website Investor relations